Skip Navigation

European Heart Journal 2000 21(22):1810-1812; doi:10.1053/euhj.2000.2193
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mahon, N.G.
Right arrow Articles by Mckenna, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahon, N.G.
Right arrow Articles by Mckenna, W.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Genes and acquired disease: beta-adrenoceptor polymorphisms and heart failure

N.G. Mahon and W.J. Mckenna

Department of Cardiological Sciences, St George's Hospital Medical School, London, U.K.

References

  1. Dawkins RL. The selfish gene. Oxford: Oxford University Press; 1989.
  2. Feldman AM, Cates AE, Veazey WB. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988;82:189–197[Web of Science][Medline]
  3. Pende A, Tremmel KD, DeMaria CT. Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway. J Biol Chem. 1996;271:8493–8501[Abstract/Free Full Text]
  4. Mann DL, Kent RL, Parsons B, Cooper G4. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85:790–804[Abstract/Free Full Text]
  5. Lancet. 1999;353:9–13[CrossRef][Web of Science][Medline]
  6. Lancet. 1999;353:2001–2007[CrossRef][Web of Science][Medline]
  7. Green SA, Cole G, Jacinto M, Innis Mt, Liggett SB. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem. 1993;268:23116–23121[Abstract/Free Full Text]
  8. Liggett SB, Wagoner LE, Craft LL. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest. 1998;102:1534–1539[Web of Science][Medline]
  9. Brodde OE, Zerkowski HR, Doetsch N, Motomura S, Khamssi, Michel MC. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol. 1989;14:323–331[Abstract]
  10. Bristow MR, Ginsburg R, Umans V. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down- regulation in heart failure. Circ Res. 1986;59:297–309[Abstract/Free Full Text]
  11. Bristow MR. beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558–569[Free Full Text]
  12. Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation. 1999;100:2210–2212[Abstract/Free Full Text]
  13. Börjesson M, Magnusson Y, Hjalmarson , Andersson B. A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J. 2000;21:1853–1858[Abstract/Free Full Text]
  14. Schafer AJ, Hawkins JR. DNA variation and the future of human genetics. Nat Biotechnol. 1998;16:33–39[Web of Science][Medline]
  15. Gerhold D, Rushmore T, Caskey CT. DNA chips: promising toys have become powerful tools. Trends Biocheml Sci. 1999;24:168–173

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
R.A de Boer and D.J van Veldhuisen
Polypharmacy in chronic heart failure: practical issues regarding the use of angiotensin-converting enzyme inhibitors, beta-blockers and other drugs
Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D111 - D116.
[Abstract] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mahon, N.G.
Right arrow Articles by Mckenna, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahon, N.G.
Right arrow Articles by Mckenna, W.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?